TRITAC
Live / Registered — Registered — partial Sections 8 & 15 accepted and acknowledged (as of 17 Mar 2025)
What this means for you
Registered since 25 Jun 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87270473
- Registration number
- 5788225
- Mark type
- Stylized text
- Filed
- 15 Dec 2016
- Published for opposition
- 02 May 2017
- Registered
- 25 Jun 2019
- Attorney of record
- Lisa M. Dellamura
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors
- Class 042 — Scientific and technological services: [Pharmaceutical research and development]
Owner
- Harpoon Therapeutics, Inc., South San Francisco, CA, US
- Harpoon Therapeutics, Inc., South San Francisco, CA, US
- Harpoon Therapeutics, Inc., Brisbane, CA, US
Prosecution history
- 17 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Mar 2025 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Nov 2024 — TEAS SECTION 8 & 15 RECEIVED
- 25 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Apr 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Apr 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Apr 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 25 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 23 May 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 May 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 May 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 May 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE